Quantcast

Latest Hyperlipidemia Stories

2014-07-21 12:24:55

Agents That Reduce the Incidence of Cardiovascular Adverse Events Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass., July 21, 2014 /PRNewswire/ -- Decision Resources Group finds that Amgen's evolocumab (AMG-145) is set to become the clinical gold-standard among statin add-on therapies used to treat patients with dyslipidemia. The competitive advantages this proprotein convertase subtilisin/kexin type 9 (PCSK9)...

2014-05-29 08:28:37

Kurt Warner and wife, Brenda, motivate the 71 million Americans living with high cholesterol to win big by committing to heart health NEW YORK, May 29, 2014 /PRNewswire/ -- National heart-health initiative, First and Goal, today announced the launch of a consumer sweepstakes encouraging those living with high cholesterol and their support systems to join the First and Goal Team and pledge to prioritize heart health. The Campaign is a partnership with Kurt Warner, Super Bowl champion and...

2014-05-06 04:23:22

WILMINGTON, Del., May 6, 2014 /PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced the US Food and Drug Administration (FDA) approved EPANOVA(®) (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL). To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/7192251-astrazeneca-fda-approval EPANOVA is the first FDA approved...

2014-05-02 08:25:43

Data suggest lower risk of major adverse cardiovascular events and death, especially in patients with diabetes or prior coronary heart disease ORLANDO, Fla., May 2, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data suggesting that the use of a target low-density lipoprotein...

2014-02-12 08:29:41

New Published Study Reveals BergaMet(TM) Added to Statins Enhances Lipid Lowering and Artery Health DENVER, Feb. 12, 2014 /PRNewswire/ -- New published research reveals that a highly concentrated proprietary extract of the Calabrian bergamot fruit called BergaMet(TM) (38% citrus bergamot extract, NathealthSolutions) enhances the effect of the lipid lowering drug rosuvastatin (Crestor(TM)) when given to patients with elevated cholesterol. Led by cardiologists Franco Romeo and Vincenzo Mollace,...

2014-02-04 11:23:37

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues. Patients with type 2 diabetes (T2DM) are at increased risk for decline in cognitive function, for reduced brain volume and increased white matter lesions on brain imaging,...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related